Maria Grazia Ennas

Maria Grazia Ennas

Auto-generated profile, based on publicly available information

Maria Grazia Ennas

University of Cagliari

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2007 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
BBBiancamaria Baroli
Biancamaria Baroli
MEMaria Grazia Ennas
Maria Grazia Ennas
FLFelice Loffredo
Felice Loffredo
MIMichela Isola
Michela Isola
RPRaimondo Pinna
Raimondo Pinna
MLM. Arturo López-Quintela
M. Arturo López-Quintela

1 January 2006 in The Lancet Oncology
Verified
Journal Article
Closed access
NRNathaniel Rothman
Nathaniel Rothman
CSChristine F Skibola
Christine F Skibola
SWSophia S Wang
Sophia S Wang
GMGareth John Morgan
Gareth John Morgan
QLQing Lan
Qing Lan
ANAlexandra Nieters
Alexandra Nieters

25 April 2003 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
Domenico RibattiDomenico Ribatti
Domenico Ribatti
MEM. G. Ennas
M. G. Ennas
AVAngelo VACCA
Angelo VACCA
FFF. Ferreli
F. Ferreli
BNB. Nico
B. Nico
PSP. Sirigu
P. Sirigu

16 June 2013 in Nature Genetics
Verified
Journal Article
Open access
PDF file
SBSonja I Berndt
Sonja I Berndt
CSChristine F Skibola
Christine F Skibola
VJVijai Joseph
Vijai Joseph
NCNicola J Camp
Nicola J Camp
ANAlexandra Nieters
Alexandra Nieters
Susan L. SlagerSusan L. Slager
Susan L. Slager
Susan Slager and colleagues report a meta-analysis of genome-wide association studies for chronic lymphocytic leukemia (CLL). They identify nine loci newly associated with CLL. Genome-wide association studies (GWAS) have previously identified 13 loci associated with risk of chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL). To identify additional CLL susceptibility loci, we conducted the largest meta-analysis for CLL thus far, including four GWAS with a total of 3,100 individuals with CLL (cases) and 7,667 controls. In the meta-analysis, we identified ten independent associated SNPs in nine new loci at 10q23.31 (ACTA2 or FAS (ACTA2/FAS), P = 1.22 × 10−14), 18q21.33 (BCL2, P = 7.76 × 10−11), 11p15.5 (C11orf21, P = 2.15 × 10−10), 4q25 (LEF1, P = 4.24 × 10−10), 2q33.1 (CASP10 or CASP8 (CASP10/CASP8), P = 2.50 × 10−9), 9p21.3 (CDKN2B-AS1, P = 1.27 × 10−8), 18q21.32 (PMAIP1, P = 2.51 × 10−8), 15q15.1 (BMF, P = 2.71 × 10−10) and 2p22.2 (QPCT, P = 1.68 × 10−8), as well as an independent signal at an established locus (2q13, ACOXL, P = 2.08 × 10−18). We also found evidence for two additional promising loci below genome-wide significance at 8q22.3 (ODF1, P = 5.40 × 10−8) and 5p15.33 (TERT, P = 1.92 × 10−7). Although further studies are required, the proximity of several of these loci to genes involved in apoptosis suggests a plausible underlying biological mechanism.

3 November 2010 in Neuropsychopharmacology
Verified
Journal Article
Closed access
SLSalvatore Lecca
Salvatore Lecca
Miriam MelisMiriam Melis
Miriam Melis
LAntonio Luchicchi
Antonio Luchicchi
MEMaria Grazia Ennas
Maria Grazia Ennas
MCM Paola Castelli
M Paola Castelli
MPMarco Pistis
Marco Pistis

2 March 2006 in Leukemia
Verified
Journal Article
Open access
PDF file
CMC Meyer
C Meyer
BSB Schneider
B Schneider
SJS Jakob
S Jakob
SSSabine Strehl
Sabine Strehl
AAA Attarbaschi
A Attarbaschi
RMRolf Marschalek
Rolf Marschalek
Chromosomal rearrangements of the human MLL gene are a hallmark for aggressive (high-risk) pediatric, adult and therapy-associated acute leukemias. These patients need to be identified in order to subject these patients to appropriate therapy regimen. A recently developed long-distance inverse PCR method was applied to genomic DNA isolated from individual acute leukemia patients in order to identify chromosomal rearrangements of the human MLL gene. We present data of the molecular characterization of 414 samples obtained from 272 pediatric and 142 adult leukemia patients. The precise localization of genomic breakpoints within the MLL gene and the involved translocation partner genes (TPGs) was determined and several new TPGs were identified. The combined data of our study and published data revealed a total of 87 different MLL rearrangements of which 51 TPGs are now characterized at the molecular level. Interestingly, the four most frequently found TPGs (AF4, AF9, ENL and AF10) encode nuclear proteins that are part of a protein network involved in histone H3K79 methylation. Thus, translocations of the MLL gene, by itself coding for a histone H3K4 methyltransferase, are presumably not randomly chosen, rather functionally selected.